Strategy

Europe's biotech entrepreneurs

Read more

The case for value-based pricing

Read more

Bill Gates backs Alzheimer's disease research

Read more

Priorities of the new Novartis CEO

Read more

Detecting cancer using liquid biopsy

Read more

Assessing the threat from drug-resistant bacteria

Read more

Building multifunctional biologics to treat disease

Read more

Regulatory challenges for cell therapy manufacture

Read more

Artificial intelligence in drug development

Read more

Long-term strategies for immuno-oncology

Read more